ijms-logo

Journal Browser

Journal Browser

New Insights in Biomarkers of Autoimmune and Autoinflammatory Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: 30 August 2024 | Viewed by 611

Special Issue Editors


E-Mail Website
Guest Editor
1. Dipartimento di Medicina e Chirurgia Traslazionale, Sezione di Patologia Generale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
2. Fondazione Policlinico Universitario “A. Gemelli” IRCCS, 00168 Rome, Italy
Interests: immunology; autoimmunity; inflammation; biomarkers
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Head of Clinical Pathology Unit, Hospital “Santa Maria Goretti” ASL Latina, 04100 Latina, Italy
Interests: autoimmunity; cancer; monoclonal gammopathy; minimal residual disease; biomarkers; other biological fluid; new technologies
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The deregulation of innate and adaptive immune systems affects 5% of the worldwide population with a high impact in terms of clinical impairment, morbidity, and, due to the chronic conditions, a significant economic burden in the long run. Inflammation, the long arm of innate immunity, as a mediator of effects may be involved or deregulated in itself, in absence of an auto-attack of the immune system, paving the way for those conditions included under the umbrella name of autoinflammatory diseases. Accordingly, cellular and molecular biomarkers are largely involved in diagnosis, prognosis, response to therapies, and follow-up, providing a prediction of changes in disease activity. Taking into account the individual and genetic susceptibility as well as the wide range of environment risk factors that concur with the pathogenesis, the importance of research to set-up and validate novel, effective, and personalised biomarkers of autoimmune and autoinflammatory conditions stands alone. This Special Issue is devoted to the most recent results aimed at exploiting the clinical potential of biomarkers measuring the disordered immune response.

Potential topics include, but are not limited to:

  • Innate immunity;
  • Adaptive immunity;
  • Inflammation;
  • Immunoglobulins;
  • Autoantibodies;
  • Free light chains;
  • Peptides;
  • Cytokines;
  • Receptors;
  • Leukocytes;
  • Extracellular vesicles;
  • Signal transduction;
  • Inflammaging;
  • Inflammasome.

Dr. Mariapaola Marino
Dr. Umberto Basile
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

 

Keywords

  • inflammaging
  • inflammasome
  • autoantibodies
  • free light chains
  • cytokines
  • receptor
  • signal transduction
  • innate immunity
  • adaptive immunity

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 1080 KiB  
Review
Autoimmunity, New Potential Biomarkers and the Thyroid Gland—The Perspective of Hashimoto’s Thyroiditis and Its Treatment
by Ewa Tywanek, Agata Michalak, Joanna Świrska and Agnieszka Zwolak
Int. J. Mol. Sci. 2024, 25(9), 4703; https://doi.org/10.3390/ijms25094703 - 26 Apr 2024
Viewed by 377
Abstract
Autoimmune thyroid disease (AITD) is the most common organic specific illness of the thyroid gland. It may manifest as the overproduction or the decline of thyroxine and triiodothyronine. Hyperthyroidism develops due to the overproduction of hormones as an answer to the presence of [...] Read more.
Autoimmune thyroid disease (AITD) is the most common organic specific illness of the thyroid gland. It may manifest as the overproduction or the decline of thyroxine and triiodothyronine. Hyperthyroidism develops due to the overproduction of hormones as an answer to the presence of stimulatory antibodies against the TSH receptor. Hashimoto’s thyroiditis (HT) is generally characterized by the presence of thyroid peroxidase and thyroglobulin antibodies, with a concomitant infiltration of lymphocytes in the thyroid. Due to the progressive destruction of cells, AITD can lead to subclinical or overt hypothyroidism. Pathophysiology of AITD is extremely complicated and still not fully understood, with genetic, environmental and epigenetic factors involved in its development. Due to increasing incidence and social awareness of this pathology, there is an urgent need to expand the background concerning AITD. A growing body of evidence suggests possible ways of treatment apart from traditional approaches. Simultaneously, the role of potential new biomarkers in the diagnosis and monitoring of AITD has been highlighted recently, too. Therefore, we decided to review therapeutic trends in the course of AITD based on its pathophysiological mechanisms, mainly focusing on HT. Another aim was to summarize the state of knowledge regarding the role of new biomarkers in this condition. Full article
Show Figures

Figure 1

Back to TopTop